The store will not work correctly when cookies are disabled.
3-(naphthalen-2-yl)-8a-(pyridin-2-yl)indolizin-1(8aH)-one
ID: ALA4763373
PubChem CID: 149290170
Max Phase: Preclinical
Molecular Formula: C23H16N2O
Molecular Weight: 336.39
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: O=C1C=C(c2ccc3ccccc3c2)N2C=CC=CC12c1ccccn1
Standard InChI: InChI=1S/C23H16N2O/c26-22-16-20(19-11-10-17-7-1-2-8-18(17)15-19)25-14-6-4-12-23(22,25)21-9-3-5-13-24-21/h1-16H
Standard InChI Key: XURKKQQRLFKECN-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 30 0 0 0 0 0 0 0 0999 V2000
19.6165 -15.0183 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6154 -15.8448 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3294 -16.2573 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3276 -14.6059 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0423 -15.0147 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0472 -15.8449 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.8382 -16.0968 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.3224 -15.4223 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8303 -14.7536 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0805 -13.9682 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.0373 -14.1900 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7514 -13.7753 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7467 -12.9513 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0296 -12.5424 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3155 -12.9636 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3237 -13.7861 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.0975 -16.8789 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5479 -17.4945 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8065 -18.2762 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9016 -17.0436 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.1632 -17.8229 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6137 -18.4411 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8748 -19.2241 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6849 -19.3900 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.2335 -18.7666 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.9696 -17.9861 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 6 1 0
5 4 1 0
4 1 2 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 5 1 0
9 10 2 0
5 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
17 18 2 0
18 19 1 0
19 22 2 0
21 20 2 0
20 17 1 0
7 17 1 0
21 22 1 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 21 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 336.39 | Molecular Weight (Monoisotopic): 336.1263 | AlogP: 4.44 | #Rotatable Bonds: 2 |
Polar Surface Area: 33.20 | Molecular Species: NEUTRAL | HBA: 3 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 4.34 | CX LogP: 4.42 | CX LogD: 4.42 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.69 | Np Likeness Score: -0.01 |
References
1. Zhang JT,Wang LX,Yang FM,Yang L,Liu Y,Tang YL. (2021) Selective recognition of DNA parallel G-quadruplexes by 3,8a-disubstituted indolizinones., 29 [PMID:33189508] [10.1016/j.bmc.2020.115848] |